INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| 13.1 billion | 17.6% CAGR | North America |
| by Technology Type | by Application | by End User |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Genome Engineering Market Overview
The Global genome engineering market is expected to grow at more than 17.6% CAGR from 2018 to 2025. It is expected to reach above USD 13.1 billion by 2025 from USD 4.6 billion in 2018.
Genome engineering entails the deliberate manipulation of Deoxyribonucleic acid (DNA) within the genome of a living organism, involving processes such as insertion, deletion, modification, or replacement of genetic material. Scientists engage in extensive research and development endeavors in genome engineering to advance novel technologies within this field.
Recent market expansion primarily stems from heightened demand for synthetic genes and increased adoption of CRISPR genome editing technology across various biotechnological sectors. This growth trajectory is further bolstered by augmented government funding, escalated production of genetically modified crops, and a surge in genomics projects.
Moreover, the proliferation of CRISPR-based diagnostic tools, notably contributing to COVID-19 diagnostics, fuels market expansion. For example, researchers at Nanyang Technological University developed the VaNGuard (Variant Nucleotide Guard) diagnostic test, which identifies SARS-CoV-2 strains with mutations, thereby enhancing the utilization of CRISPR genome editing technology in the diagnostics sector.
The global regulatory landscape governing genome engineering is characterized by an intricate framework of guidelines, regulations, and ethical considerations established by diverse governmental bodies, international entities, and scientific communities worldwide. These frameworks are designed to ensure the responsible and safe application of genome editing technologies, including CRISPR-Cas9, zinc finger nucleases, and TALENs, across various domains such as agriculture, medicine, and biotechnology.
Fundamental elements of these regulations encompass risk assessment, oversight of genome editing research, informed consent procedures, transparent communication practices, and careful consideration of societal and ethical implications. While certain regions have enacted specific legislation or guidelines governing genome editing, such as the European Union’s regulations on genetically modified organisms (GMOs) or the FDA‘s regulatory directives in the United States, ongoing efforts in international collaboration and harmonization seek to address the multifaceted challenges associated with genome engineering technologies on a global scale.
Genome Engineering Market Segment Analysis
On the basis of technology type, the global genome engineering market has been segmented as – CRISPR, TALEN, ZFN, and other genome engineering or genetic engineering technologies. The others category includes antisense technology and mega nucleases.
Based on application, the genome engineering market is divided into five segments, gene therapy, disease models, functional genomics, knockdown/activation and other applications. Genetic engineers have developed genetic recombination techniques or genome engineering techniques to manipulate gene sequences in plants, animals and other organisms to express specific traits. Applications for genetic engineering are increasing as engineers and scientists work together to identify the locations and functions of specific genes in the DNA sequence of various organisms.
End user segment of the global genome engineering market includes academic and government research institutes, biotechnology and pharmaceutical companies, contract research organizations, and other end users. It also includes biopharmaceutical companies. Biotechnology and pharmaceutical companies are one of the major end users of the genome engineering market. These companies are incorporating numerous CRISPR gene editing products and services for the treatment and screening of genetic disorders.
Genome Engineering Market Players
Abcam, Inc., is one of the emerging players in the CRISPR gene editing market. The global life sciences company develops biological reagents and tools required in drug discovery, basic research, diagnostics, and other fields and applications. The company offers research-based only proteomic tools, antibodies, protein binding reagents, and immunoassays to researchers and scientists in academic institutes, biotechnology, diagnostics, and pharmaceuticals companies for studying biological pathways critical in scientific research, drug discovery, and diagnostics.
Applied StemCell, Inc., headquartered in California, US, is one of the emerging private players in the gene editing market. The company develops gene modification technologies enabling stem cell and genome engineering to augment revolutionary biomedical and industrial research and applications. The company’s competitors that cater to the CRISPR gene editing market include System Biosciences LLC, Horizon Discovery Group PLC, Takara Bio, GeneCopoeia, Inc., and Cellecta, Inc., among others.
- In 2020, New England Biolabs collaborated with ERS Genomics to develop and commercialize CRISPR gene editing tools and reagents
- In 2019, Thermo Fisher Scientific acquired Brammer Bio to access Brammer Bio’s expertise in manufacturing vectors for genes and cell therapies
- In 2019, Horizon Discovery launched predesigned synthetic single-guide RNA (sgRNA) to aid researchers in achieving targeted gene knockouts and conducting DNA-gene free editing.
Who Should Buy? Or Key Stakeholders
- Research Centers
- Large Firms
- Regulatory Body
- Pharma & Biotech Companies/CROs/CDMOs/Researchers
- Investors
- Vaccine Manufacturers
- Fertility Clinics
- Drug Companies
- Clinical Testing Companies
Genome Engineering Market Regional Analysis
The Genome Engineering Market by region includes North America, Europe, Asia-Pacific (APAC), South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
The North America region is currently dominating the global genome engineering market (by region). Several conglomerate and small-medium enterprises are focused on collaborating with each other and other distributing channels to expand their global reach by developing more cost-effective and advanced products is consequentially promoting the growth of the global genome engineering market.
Key Market Segments: Genome Engineering Market
Genome Engineering Market by Technology Type, 2018-2025, (In USD Million)
- CRISPR
- TALEN
- ZFN
- Others
Genome Engineering Market by Application, 2018-2025, (In USD Million)
- Gene Therapy
- Disease Modules
- Functional Genomics
- Knockdown/Activation
- Other Applications
Genome Engineering Market by End User, 2018-2025, (In USD Million)
- Biotechnology & Pharmaceutical Companies
- Contract Research Organizations
- Academic & Government Research Institutes
- Other End Users
Genome Engineering Market by Region, 2018-2025, (In USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East and Africa
Important countries in all regions are covered (Total country profiles 25)
Key Question Answered
- Who are the major players in the genome engineering market?
- What are the regional growth trends and the largest revenue-generating regions in the genome engineering market?
- What are the major drivers and challenges in the genome engineering market?
- What are the major application segments in the genome engineering market?
- What are the major end users in the genome engineering market?
Table of Content
- SCOPE OF THE REPORT
- MARKET INTRODUCTION
- YEARS CONSIDERED
- RESEARCH OBJECTIVES
- MARKET RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- RESEARCH FLOW
- DATA MINING
- DATA SOURCES
- CURRENCY CONSIDERED
- MARKET OVERVIEWS
- INTRODUCTION
- MARKET OUTLOOK
- ROLE OF RNA IN SIMPLIFYING GENE THERAPY DEVELOPMENT
- ADVANTAGES OVER DNA BASED GENE THERAPIES
- BREAKTHROUGH APPROVALS
- COMPANIES WORKING TOWARDS RNA BASED THERAPIES
- RNAI THERAPEUTICS MARKET IS ATTRACTING INVESTMENTS
- CELL LINE DEVELOPMENT
- MARKET DYNAMICS
- MARKET DRIVERS
- PREVALENCE OF GENETIC DISORDERS AND USE OF GENOME EDITING
- GOVERNMENT AND PRIVATE FUNDING
- TECHNOLOGY ADVANCEMENT IN CRISPR GENE EDITING
- MARKET RESTRAINTS
- CRISPR GENE EDITING: OFF TARGET EFFECTS AND DELIVERY
- ETHICAL CONCERNS AND IMPLICATIONS WITH RESPECT TO HUMAN GENOME EDITING
- MARKET OPPORTUNITIES
- EXPANDING GENE AND CELL THERAPY AREA
- CRISPR GENE EDITING SCOPE IN AGRICULTURE
- COVID-19 IMPACT OVERVIEW
- COVID-19 IMPACT INSIGHTS
- COVID-19 IMPACT ASSESSMENT ON THE GENOME ENGINEERING MARKET
- COVID-19 IMPACT ASSESSMENT ON THE CRISPER TECHNOLOGY MARKET
- PESTEL ANALYSIS
- POLITICAL & LEGAL
- ECONOMIC
- SOCIAL
- TECHNOLOGICAL
- ENVIRONMENTAL
- PORTERS FIVE FORCES ANALYSIS
- BARGAINING POWER OF BUYERS
- BARGAINING POWER OF SUPPLIERS
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTES
- COMPETITIVE RIVALRY
- PRICING ANALYSIS – CRISPR VS TALEN VS ZFN
- VALUE CHAIN ANALYSIS
- KEY STAKEHOLDERS IN VALUE CHAIN
- NORTH AMERICA
- EUROPE
- SOUTH AMERICA
- APAC
- MIDDLE EAST AND AFRICA
- MARKET DRIVERS
- GLOBAL GENOME ENGINEERING MARKET BY TECHNOLOGY TYPE
- INTRODUCTION
- CRISPR GENE EDITING CURRENT SCENARIO AND FUTURE POTENTIAL APPLICATION AREAS
- CRISPR
- TALEN
- ZFN
- OTHER TECHNOLOGIES
- INTRODUCTION
- GLOBAL GENOME ENGINEERING MARKET BY APPLICATION
- INTRODUCTION
- GENE THERAPY
- DISEASE MODULES
- FUNCTIONAL GENOMICS
- KNOCKDOWN/ACTIVATION
- OTHER APPLICATIONS
- GLOBAL GENOME ENGINEERING MARKET BY END USER
- INTRODUCTION
- BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
- ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
- CONTRACT RESEARCH ORGANIZATIONS
- OTHER END USERS
- GLOBAL GENOME ENGINEERING MARKET BY REGION
- INTRODUCTION
- NORTH AMERICA
- US
- CANADA
- MEXICO
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- APAC
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- AUSTRALIA
- ASEAN
- REST OF APAC
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- REST OF SOUTH AMERICA
- MEA
- UAE
- SAUDI ARABIA
- TURKEY
- SOUTH AFRICA
- REST OF MEA
- KEY PLAYERS ANALYSIS
- ABCAM, INC.
- COMPANY OVERVIEW
- ROLE OF ABCAM, INC. IN THE GLOBAL GENOME ENGINEERING MARKET
- PRODUCTS OFFERED
- KEY DEVELOPMENTS
- KEY FINANCIALS
- SWOT ANALYSIS
- APPLIED STEMCELL, INC
- COMPANY OVERVIEW
- ROLE OF APPLIED STEMCELL, INC. IN THE GLOBAL GENOME ENGINEERING MARKET
- PRODUCTS OFFERED
- KEY DEVELOPMENTS
- SWOT ANALYSIS
- AGILENT TECHNOLOGIES, INC.
- COMPANY OVERVIEW
- ROLE OF AGILENT TECHNOLOGIES, INC. IN THE GLOBAL GENOME ENGINEERING MARKET
- KEY DEVELOPMENTS
- KEY FINANCIALS
- SWOT ANALYSIS
- CELLECTA, INC.
- COMPANY OVERVIEW
- ROLE OF CELLECTA, INC. IN THE GLOBAL GENOME ENGINEERING MARKET
- PRODUCTS OFFERED
- KEY DEVELOPMENTS
- SWOT ANALYSIS
- CRISPR THERAPEUTICS AG
- COMPANY OVERVIEW
- ROLE OF CRISPR THERAPEUTICS AG IN THE GLOBAL GENOME ENGINEERING MARKET
- PRODUCTS OFFERED
- KEY DEVELOPMENTS
- KEY FINANCIALS
- SWOT ANALYSIS
- THERMO FISHER SCIENTIFIC, INC
- COMPANY OVERVIEW
- ROLE OF THERMO FISHER SCIENTIFIC, INC. IN THE GLOBAL GENOME ENGINEERING MARKET
- PRODUCTS OFFERED
- KEY DEVELOPMENTS
- KEY FINANCIALS
- SWOT ANALYSIS
- GENESCRIPT BIOTECH CORPORATION
- COMPANY OVERVIEW
- ROLE OF GENESCRIPT BIOTECH CORPORATION IN THE GLOBAL GENOME ENGINEERING MARKET
- PRODUCTS OFFERED
- KEY DEVELOPMENTS
- KEY FINANCIALS
- SWOT ANALYSIS
- HORIZON DISCOVERY GROUP PLC
- COMPANY OVERVIEW
- ROLE OF HORIZON DISCOVERY GROUP PLC IN THE GLOBAL GENOME ENGINEERING MARKET
- PRODUCTS OFFERED
- KEY DEVELOPMENTS
- KEY FINANCIALS
- SWOT ANALYSIS
- MERCK KGAA
- COMPANY OVERVIEW
- ROLE OF MERCK KGAA IN THE GLOBAL GENOME ENGINEERING MARKET
- PRODUCTS OFFERED
- KEY DEVELOPMENTS
- KEY FINANCIALS
- SWOT ANALYSIS
- SYNTHEGO CORPORATION
- COMPANY OVERVIEW
- ROLE OF SYNTHEGO CORPORATION IN THE GLOBAL GENOME ENGINEERING MARKET
- PRODUCTS OFFERED
- KEY DEVELOPMENTS
- SWOT ANALYSIS
- TAKARA BIO
- COMPANY OVERVIEW
- ROLE OF TAKARA BIO IN THE GLOBAL GENOME ENGINEERING MARKET
- PRODUCTS OFFERED
- KEY FINANCIALS
- SWOT ANALYSIS
- ABCAM, INC.
LIST OF TABLES
TABLE 1 Â Â Â Â Â Â Â Â Â Â Â Â Â Â KEY DISCOVERIES IN THE HISTORY OF GENOME ENGINEERING
TABLE 2 Â Â Â Â Â Â Â Â Â Â Â Â Â Â PRIVATE COMPANY INVESTMENTS IN CRISPR GENE EDITING
TABLE 3 Â Â Â Â Â Â Â Â Â Â Â Â Â Â COST OF CRISPR GENE EDITING
TABLE 4 CRISPR EXHIBITS MOST POTENTIAL AS COMPARED TO OTHER GENE EDITING TECHNOLOGIES
TABLE 5 Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL GENOME ENGINEERING MARKET, BY TECHNOLOGIE TYPE, 2018-2025, USD MILLION
TABLE 6 Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL CRISPR MARKET, BY KITS AND ENZYME TYPES, 2018-2025, USD MILLION
TABLE 7 Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL CRISPR TECHNOLOGY MARKET, BY REGION, 2018-2025, USD MILLION
TABLE 8 Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL VECTOR-BASED CAS9, BY REGION, 2018-2025, USD MILLION
TABLE 9 Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL DNA-FREE CAS9, BY REGION, 2018-2025, USD MILLION
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL TELEN TECHNOLOGY MARKET, BY REGION, 2018-2025, USD MILLION
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ZFN TECHNOLOGY MARKET, BY REGION, 2018-2025, USD MILLION
TABLE 12 Â Â Â Â Â Â Â Â Â Â Â GLOBAL OTHER GENOME ENGINEERING TECHNOLOGY MARKET, BY REGION, 2018-2025, USD MILLION
TABLE 13 Â Â Â Â Â Â Â Â Â Â Â GLOBAL GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 14 Â Â Â Â Â Â Â Â Â Â Â GLOBAL GENE THERAPY MARKET, BY REGION, 2018-2025, USD MILLION TABLE 15 MODELS USED TO STUDY GENETIC PRINCIPLES AND HUMAN DISEASES
TABLE 16 Â Â Â Â Â Â Â Â Â Â Â GLOBAL DISEASE MODEL MARKET, BY REGION, 2018-2025, USD MILLION TABLE 17 GLOBAL FUNCTIONAL GENOMICS MARKET, BY REGION, 2018-2025, USD MILLION
TABLE 18 Â Â Â Â Â Â Â Â Â Â Â GLOBAL KNOCKDOWN/ACTIVATION MARKET, BY REGION, 2018-2025, USD MILLION
TABLE 19 Â Â Â Â Â Â Â Â Â Â Â GLOBAL OTHER GENOME ENGINEERING APPLICATIONS MARKET, BY REGION, 2018-2025, USD MILLION
TABLE 20 Â Â Â Â Â Â Â Â Â Â Â GLOBAL GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 21 Â Â Â Â Â Â Â Â Â Â Â GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET, BY REGION, 2018-2025, USD MILLION
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL ACADEMIC & GOVERNMENT RESEARCH INSTITUTES MARKET, BY REGION, 2018- 2025, USD MILLION
TABLE 23 Â Â Â Â Â Â Â Â Â Â Â GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET, BY REGION, 2018-2025, USD MILLION
TABLE 24 Â Â Â Â Â Â Â Â Â Â Â GLOBAL OTHER END USERS MARKET, BY REGION, 2018-2025, USD MILLION
TABLE 25 Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA GENOME ENGINEERING MARKET, BY COUNTRIES, 2018-2025, USD MILLION
TABLE 26 Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 27 Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 28 Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 29 Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 30 Â Â Â Â Â Â Â Â Â Â Â US GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 31 Â Â Â Â Â Â Â Â Â Â Â US GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 32 Â Â Â Â Â Â Â Â Â Â Â US GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION TABLE 33 US CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION TABLE 34 CANADA GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 35 Â Â Â Â Â Â Â Â Â Â Â CANADA GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 36 Â Â Â Â Â Â Â Â Â Â Â CANADA GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 37 Â Â Â Â Â Â Â Â Â Â Â CANADA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 41 Â Â Â Â Â Â Â Â Â Â Â MRXICO CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD Â Â MILLION
TABLE 42 Â Â Â Â Â Â Â Â Â Â Â EUROPE GENOME ENGINEERING MARKET, BY COUNTRIES, 2018-2025, USD MILLION
TABLE 43 Â Â Â Â Â Â Â Â Â Â Â EUROPE GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 45 Â Â Â Â Â Â Â Â Â Â Â EUROPE GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 46 Â Â Â Â Â Â Â Â Â Â Â EUROPE CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 47 Â Â Â Â Â Â Â Â Â Â Â GERMANY GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 48 Â Â Â Â Â Â Â Â Â Â Â GERMANY GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 50 Â Â Â Â Â Â Â Â Â Â Â GERMANY CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 51 Â Â Â Â Â Â Â Â Â Â Â UK GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 52 Â Â Â Â Â Â Â Â Â Â Â UK GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â UK GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 54 Â Â Â Â Â Â Â Â Â Â Â UK CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION TABLE 55 FRANCE GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 56 Â Â Â Â Â Â Â Â Â Â Â FRANCE GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 57 Â Â Â Â Â Â Â Â Â Â Â FRANCE GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 58 Â Â Â Â Â Â Â Â Â Â Â FRANCE CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 59 Â Â Â Â Â Â Â Â Â Â Â ITALY GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 62 Â Â Â Â Â Â Â Â Â Â Â ITALY CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION TABLE 63 SPAIN GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 64 Â Â Â Â Â Â Â Â Â Â Â SPAIN GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 65 Â Â Â Â Â Â Â Â Â Â Â SPAIN GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 66 Â Â Â Â Â Â Â Â Â Â Â SPAIN CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION TABLE 67 RUSSIA GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 68 Â Â Â Â Â Â Â Â Â Â Â RUSSIA OF EUROPE GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 69 Â Â Â Â Â Â Â Â Â Â Â RUSSIA OF EUROPE GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 70 Â Â Â Â Â Â Â Â Â Â Â RUSSIA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 71 Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 72 Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 73 Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 74 Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â APAC GENOME ENGINEERING MARKET, BY COUNTRIES, 2018-2025, USD MILLION
TABLE 76 APAC GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 77 Â Â Â Â Â Â Â Â Â Â Â APAC GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 78 Â Â Â Â Â Â Â Â Â Â Â APAC GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â APAC CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION TABLE 80 CHINA GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 81 Â Â Â Â Â Â Â Â Â Â Â CHINA GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 82Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 83 Â Â Â Â Â Â Â Â Â Â Â CHINA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION TABLE 84 JAPAN GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 85 Â Â Â Â Â Â Â Â Â Â Â JAPAN GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 86 Â Â Â Â Â Â Â Â Â Â Â JAPAN GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 87 Â Â Â Â Â Â Â Â Â Â Â JAPAN CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION TABLE 88 INDIA GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 89Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 90 Â Â Â Â Â Â Â Â Â Â Â INDIA GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 91Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 92 Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 93 Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 94 Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 95 Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 96 Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 97 Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 98 Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 99 Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 100Â Â Â Â Â Â Â Â Â Â Â ASEAN GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 101Â Â Â Â Â Â Â Â Â Â Â ASEAN GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 102 Â Â Â Â Â Â Â Â Â ASEAN GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 103 Â Â Â Â Â Â Â Â Â ASEAN CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 104 Â Â Â Â Â Â Â Â Â REST OF APAC GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 105 Â Â Â Â Â Â Â Â Â REST OF APAC GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 106 Â Â Â Â Â Â Â Â Â REST OF APAC GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 107 Â Â Â Â Â Â Â Â Â REST OF APAC CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 108 Â Â Â Â Â Â Â Â Â SOUTH AMERICA GENOME ENGINEERING MARKET, BY COUNTRIES, 2018-2025, USD MILLION
TABLE 109 Â Â Â Â Â Â Â Â Â SOUTH AMERICA GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 110 Â Â Â Â Â Â Â Â Â SOUTH AMERICA GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 111 Â Â Â Â Â Â Â Â Â SOUTH AMERICA GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 112 Â Â Â Â Â Â Â Â Â SOUTH AMERICA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 113 Â Â Â Â Â Â Â Â Â BRAZIL GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 114 Â Â Â Â Â Â Â Â Â BRAZIL GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 115 Â Â Â Â Â Â Â Â Â BRAZIL GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 116 Â Â Â Â Â Â Â Â Â BRAZIL CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 117 Â Â Â Â Â Â Â Â Â ARGENTINA GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 118 Â Â Â Â Â Â Â Â Â ARGENTINA GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 119Â Â Â Â Â Â ARGENTINA GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 120Â Â Â Â Â Â Â Â Â Â Â ARGENTINA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 121Â Â Â Â Â Â Â Â Â Â Â REST OF SA GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 122 Â Â Â Â Â Â Â Â Â REST OF SA GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 123 Â Â Â Â Â Â Â Â Â REST OF SA GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 124 Â Â Â Â Â Â Â Â Â REST OF SA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 125Â Â Â Â Â Â Â Â Â Â Â MEA GENOME ENGINEERING MARKET, BY COUNTRIES, 2018-2025, USD MILLION
TABLE 126 Â Â Â Â Â Â Â Â Â MEA GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 127 Â Â Â Â Â Â Â Â Â MEA GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 128Â Â Â Â Â Â Â Â Â Â Â MEA GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 129 Â Â Â Â Â Â Â Â Â MEA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
118 TABLE Â Â Â Â Â Â Â Â Â UAE GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 131 Â Â Â Â Â Â Â Â Â UAE GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 132Â Â Â Â Â Â Â Â Â Â Â UAE GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 133 Â Â Â Â Â Â Â Â Â UAE CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION TABLE 134 SAUDI ARABIA GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 135 Â Â Â Â Â Â Â Â Â SAUDIA ARABIA GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 136 Â Â Â Â Â Â Â Â Â SAUDIA ARABIA GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 137Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 138 Â Â Â Â Â Â Â Â Â TURKEY ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 139Â Â Â Â Â Â Â Â Â Â Â TURKEY GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 140 Â Â Â Â Â Â Â Â Â TURKEY GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 141Â Â Â Â Â Â Â Â Â Â Â TURKEY CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 142 Â Â Â Â Â Â Â Â Â SOUTH AFRICA ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 143 Â Â Â Â Â Â Â Â Â SOUTH AFRICA GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 144 Â Â Â Â Â Â Â Â Â SOUTH AFRICA GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 145Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 146 Â Â Â Â Â Â Â Â Â REST OF MEA GENOME ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2018-2025, USD MILLION
TABLE 147 Â Â Â Â Â Â Â Â Â REST OF MEA GENOME ENGINEERING MARKET, BY APPLICATION, 2018-2025, USD MILLION
TABLE 148Â Â Â Â Â Â Â Â Â Â Â REST OF MEA GENOME ENGINEERING MARKET, BY END USER, 2018-2025, USD MILLION
TABLE 149 Â Â Â Â Â Â Â Â Â REST OF MEA CRISPR MARKET, BY KIT AND ENZYME TYPE, 2018-2025, USD MILLION
TABLE 150 Â Â Â Â Â Â Â Â Â COMPANY OVERVIEW ABCAM, INC. 127 TABLE 151 PRODUCTS OFFERED ABCAM, INC.
TABLE 152 Â Â Â Â Â Â Â Â Â KEY DEVELOPMENTS ABCAM, INC. 128 TABLE 153 KEY FINANCIALS ABCAM, INC.
TABLE 154 Â Â Â Â Â Â Â Â Â COMPANY OVERVIEW APPLIED STEMCELL, INC. TABLE 155 PRODUCTS OFFERED APPLIED STEMCELL, INC.
TABLE 156Â Â Â Â Â Â Â Â Â Â Â KEY DEVELOPMENTS APPLIED STEMCELL, INC.
TABLE 157 Â Â Â Â Â Â Â Â Â COMPANY OVERVIEW AGILENT TECHNOLOGIES, INC.
TABLE 158 Â Â Â Â Â Â Â Â Â PRODUCTS OFFERED AGILENT TECHNOLOGIES, INC.
TABLE 159 Â Â Â Â Â Â Â Â Â KEY DEVELOPMENTS AGILENT TECHNOLOGIES, INC.
TABLE 160 Â Â Â Â Â Â Â Â Â KEY FINANCIALS AGILENT TECHNOLOGIES, INC.
TABLE 161 Â Â Â Â Â Â Â Â Â COMPANY OVERVIEW CELLECTA INC.
TABLE 162 Â Â Â Â Â Â Â Â Â PRODUCTS OFFERED CELLECTA, INC.
TABLE 163 Â Â Â Â Â Â Â Â Â KEY DEVELOPMENTS CELLECTA, INC.
TABLE 164 Â Â Â Â Â Â Â Â Â COMPANY OVERVIEW CRISPR THERAPEUTICS AG
TABLE 165Â Â Â Â Â Â Â Â Â Â Â PRODUCTS OFFERED CRISPR THERAPEUTICS AG
TABLE 166 Â Â Â Â Â Â Â Â Â KEY DEVELOPMENTS CRISPR THERAPEUTICS AG
TABLE 167 Â Â Â Â Â Â Â Â Â KEY FINANCIALS CRISPR THERAPEUTICS AG
TABLE 168 Â Â Â Â Â Â Â Â Â COMPANY OVERVIEW THERMO FISHER SCIENTIFIC, INC.
TABLE 169 Â Â Â Â Â Â Â Â Â PRODUCTS OFFERED THERMO FISHER SCIENTIFIC, INC.
TABLE 170 Â Â Â Â Â Â Â Â Â KEY DEVELOPMENTS THERMO FISHER SCIENTIFIC, INC.
TABLE 171 Â Â Â Â Â Â Â Â Â KEY FINANCIALS THERMO FISHER SCIENTIFIC, INC.
TABLE 172 Â Â Â Â Â Â Â Â Â COMPANY OVERVIEW GENESCRIPT BIOTECH CORPORATION
TABLE 173 Â Â Â Â Â Â Â Â Â PRODUCTS OFFERED GENESCRIPT BIOTECH CORPORATION
TABLE 174 Â Â Â Â Â Â Â Â Â KEY DEVELOPMENTS GENESCRIPT BIOTECH CORPORATION
TABLE 175 Â Â Â Â Â Â Â Â Â KEY FINANCIALS GENESCRIPT BIOTECH CORPORATION
TABLE 176 Â Â Â Â Â Â Â Â Â COMPANY OVERVIEW HORIZON DISCOVERY GROUP PLC
TABLE 177 Â Â Â Â Â Â Â Â Â PRODUCTS OFFERED HORIZON DISCOVERY GROUP PLC
TABLE 178 Â Â Â Â Â Â Â Â Â KEY DEVELOPMENTS HORIZON DISCOVERY GROUP PLC
TABLE 179 Â Â Â Â Â Â Â Â Â KEY FINANCIALS HORIZON DISCOVERY GROUP PLC
TABLE 180 Â Â Â Â Â Â Â Â Â COMPANY OVERVIEW MERCK KGAA
TABLE 181 Â Â Â Â Â Â Â Â Â PRODUCTS OFFERED MERCK KGAA
TABLE 182 Â Â Â Â Â Â Â Â Â KEY DEVELOPMENTS MERCK KGAA
TABLE 183 Â Â Â Â Â Â Â Â Â KEY FINANCIALS MERCK KGAA
TABLE 184 Â Â Â Â Â Â Â Â Â COMPANY OVERVIEW SYNTHEGO CORPORATION
TABLE 185 Â Â Â Â Â Â Â Â Â PRODUCTS OFFERED SYNTHEGO CORPORATION
TABLE 186 Â Â Â Â Â Â Â Â Â KEY DEVELOPMENTS SYNTHEGO CORPORATION
TABLE 187Â Â Â Â Â Â Â Â Â Â Â COMPANY OVERVIEW TAKARA BIO
TABLE 188 Â Â Â Â Â Â Â Â Â PRODUCTS OFFERED TAKARA BIO
TABLE 189Â Â Â Â Â Â Â Â Â Â Â KEY FINANCIALS TAKARA BIO
LIST OF FIGURES
FIGURE 1 Â Â Â Â Â Â Â Â Â Â MARKET STRUCTURE
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH TIMELINES
FIGURE 3 Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â MARKET RESEARCH FLOW
FIGURE 5 Â Â Â Â Â Â Â Â Â Â DATA SOURCES
FIGURE 6 Â Â Â Â Â Â Â Â Â Â ROLE OF RNA IN SIMPLIFYING GENE THERAPY
FIGURE 7 Â Â Â Â Â Â Â Â Â Â RNAI THERAPEUTICS MARKET IS ATTRACTING INVESTMENTS (NUMBERS ARE IN USD Â Â MILLION)
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â Â CELL LINE DEVELOPMENT: KEY MARKET TRENDS
FIGURE 9 Â Â Â Â Â Â Â Â Â Â Â Â CELL LINE DEVELOPMENT BY DIFFERENT SOURCES/APPLICATIONS/TYPES
FIGURE 10          CELL LINE DEVELOPMENT – KEY MARKETS FOR SERVICES PROVIDERS
FIGURE 11Â Â Â Â Â Â Â Â Â Â MAJOR ETHICAL CONCERNS OF CRISPR GENE EDITING
FIGURE 12Â Â Â Â Â Â Â Â Â Â CRISPR GENE EDITING APPLICATIONS IN CELL AND GENE THERAPY
FIGURE 13 Â Â Â Â Â Â Â Â Â PESTEL ANALYSIS
FIGURE 14Â Â Â Â Â Â Â Â Â Â PORTERS FIVE FORCES ANALYSIS
FIGURE 15 Â Â Â Â Â Â Â Â Â VALUE CHAIN ANALYSIS
FIGURE 16Â Â Â Â Â Â Â Â Â Â KEY MILESTONES IN CRISPR GENE EDITING
FIGURE 17 Â Â Â Â Â Â Â Â Â CRISPR GENE EDITING DELIVERY METHODS
FIGURE 18 Â Â Â Â Â Â Â Â Â SWOT ANALYSIS ABCAM, INC.
FIGURE 19 Â Â Â Â Â Â Â Â Â SWOT ANALYSIS APPLIED STEMCELL, INC.
FIGURE 20 Â Â Â Â Â Â Â Â Â SWOT ANALYSIS AGILENT TECHNOLOGIES, INC.
FIGURE 21 Â Â Â Â Â Â Â Â Â SWOT ANALYSIS CELLECTA, INC.
FIGURE 22 Â Â Â Â Â Â Â Â Â SWOT ANALYSIS CRISPR THERAPEUTICS AG
FIGURE 23Â Â Â Â Â Â Â Â Â Â SWOT ANALYSIS THERMO FISHER SCIENTIFIC, INC.
FIGURE 24 Â Â Â Â Â Â Â Â Â SWOT ANALYSIS GENESCRIPT BIOTECH CORPORATION
FIGURE 25Â Â Â Â Â Â Â Â Â Â SWOT ANALYSIS HORIZON DISCOVERY GROUP PLC
FIGURE 26 Â Â Â Â Â Â Â Â Â SWOT ANALYSIS MERCK KGAA
FIGURE 27 Â Â Â Â Â Â Â Â Â SWOT ANALYSIS SYNTHEGO CORPORATION
FIGURE 28Â Â Â Â Â Â Â Â Â Â SWOT ANALYSIS TAKARA BIO
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.